Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
复制标题
DOI：
10.1016/j.drugalcdep.2022.109323
复制
发表时间：
2022-03-01
影响因子：
4.2
通讯作者：
Des Jarlais DC
中科院分区：
文献类型：
--
作者：
Behrends CN;Lu X;Corry GJ;LaKosky P;Prohaska SM;Glick SN;Kapadia SN;Perlman DC;Schackman BR;Des Jarlais DC
本研究描述了 2019 年美国注射器服务计划 (SSP) 提供的减少危害和健康服务以及 2020 年提供这些服务的变化。SSP 受邀参加 2020 年 8 月的戴夫·购买纪念调查。我们收集了 2019 年和 2020 年调查时提供的服务的程序数据。我们使用卡方检验和麦克尼马尔检验进行了描述性分析。截至调查时，超过 60% 的 SSP 报告称，与 2019 年相比，2020 年秋季每月注射器和纳洛酮的分发有所增加，并且家庭和邮寄纳洛酮递送范围有所扩大。约四分之三的 SSP 减少或停止提供现场 HIV 和 HCV 检测。 2019 年，近一半为阿片类药物使用障碍 (MOUD) 提供现场药物的 SSP 在 2020 年增加了 MOUD 的供应。从统计数据来看，从 2019 年到 2020 年秋季，提供现场心理保健服务和初级保健服务的 SSP 比例显着下降，但提供这些服务的远程医疗有所增加。许多在 2019 年提供卫生服务并在 2020 年继续运营的 SSP 增加了心理健康和初级保健服务的远程医疗提供，增加了 MOUD 的提供，并扩大了减少伤害服务，但大多数 SSP 减少或停止了现场 HIV 和 HCV 检测。 2020 年是阿片类药物流行最致命的一年，维持 SSP 的增长和创新对于预防用药过量死亡和 HIV/HCV 爆发至关重要。
This study describes harm reduction and health services provided by U.S syringe services programs (SSPs) in 2019 and changes in provision of those services in 2020. SSPs were invited to participate in the Dave Purchase Memorial survey in August 2020. We collected programmatic data on services provided in 2019 and at the time of the survey in 2020. We conducted descriptive analyses using Chi-square and McNemar’s tests. At the time of the survey, > 60% of SSPs reported increased monthly syringe and naloxone distribution and expansion of home-based and mail-based naloxone delivery in Fall 2020 compared to 2019. Approximately three-quarters of SSPs decreased or stopped providing on-site HIV and HCV testing. Nearly half of SSPs offering on-site medications for opioid use disorder (MOUD) in 2019 increased provision of MOUD in 2020. The proportion of SSPs offering on-site mental health care services and primary care services statistically significantly decreased from 2019 to Fall 2020, but telehealth offerings of these services increased. Many SSPs that offered health services in 2019 and remained operational in 2020 increased telehealth provision of mental health and primary care services, increased MOUD provision, and expanded harm reduction services, but most SSPs reduced or stopped on-site HIV and HCV testing. Sustaining SSP growth and innovation is paramount for preventing overdose deaths and HIV/HCV outbreaks after the deadliest year of the opioid epidemic in 2020.
登录
查看更多内容
DOI：
10.1016/j.drugpo.2021.103199
发表时间：
2021-08
期刊：
The International journal on drug policy
影响因子：
--
作者：
French R;Favaro J;Aronowitz SV
通讯作者：
Aronowitz SV
影响因子：
4.2
作者：
Jacka BP;Janssen T;Garner BR;Yermash J;Yap KR;Ball EL;Hartzler B;Becker SJ
通讯作者：
Becker SJ
影响因子：
33.9
作者：
Des Jarlais, Don C.;Nugent, Ann;Holtzman, Deborah
通讯作者：
Holtzman, Deborah
影响因子：
2
作者：
Behrends CN;Li CS;Gibson DR
通讯作者：
Gibson DR
DOI：
10.1007/s11524-021-00534-1
发表时间：
2021-08
期刊：
Journal of urban health : bulletin of the New York Academy of Medicine
影响因子：
--
作者：
Hayes BT;Favaro J;Davis CS;Gonsalves GS;Beletsky L;Vlahov D;Heimer R;Fox AD
通讯作者：
Fox AD